Clinical and Molecular Hepatology10.3350/cmh.2021.0277.e12022284939-939Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]Do Young Kim,,
Clinical and Molecular Hepatology10.3350/cmh.2021.02772021274620-622History and future of hepatitis B virus control in South KoreaDo Young Kim,,
Clinical and Molecular Hepatology10.3350/cmh.2022.0084.e12022284940-940Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331],,
Clinical and Molecular Hepatology10.3350/cmh.2015.21.2.1222015212122Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?Woo Sun Rou, Byung Seok Lee,,
Clinical and Molecular Hepatology10.3350/cmh.2015.21.2.1052015212105Hepatitis C virus-induced hepatocellular carcinomaNicolas Goossens, Yujin Hoshida,,
Clinical and Molecular Hepatology10.3350/cmh.2017.01052017233212-218Current status of and strategies for hepatitis C control in South KoreaBeom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim,,
Clinical and Molecular Hepatology10.3350/cmh.2014.20.3.2492014203249Occult hepatitis B virus infection: clearance or disguise?Jin-Wook Kim,,
Clinical and Molecular Hepatology10.3350/cmh.2021.0236202228191-104A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspectiveHye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong,,
Clinical and Molecular Hepatology10.3350/cmh.2022.0032202329165-76Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironmentSoo-Jeung Park, Young S. Hahn,,
Clinical and Molecular Hepatology10.3350/cmh.2013.19.1.17201319117Hepatitis C virus: virology and life cycleChang Wook Kim, Kyong-Mi Chang,,